المؤلفون: Keith L. Davis, Isabelle Côté, James A. Kaye, Estella Mendelson, Haitao Gao, Julian Perez Ronco

المصدر: Advances in Hematology, Vol 2015 (2015)

مصطلحات موضوعية: Diseases of the blood and blood-forming organs, RC633-647.5

وصف الملف: electronic resource

Relation: https://doaj.org/toc/1687-9104; https://doaj.org/toc/1687-9112

URL الوصول: https://doaj.org/article/10c9d08710124b4fb09731fe3171098a

المؤلفون: Estella Mendelson, Sahil Narkhede, Darshan Dalal, Patricia Brandt, Mei Sheng Duh, Lynn Huynh, Diego Cortina, Jorge E. Cortes, Maral DerSarkissian

المصدر: Leukemialymphoma. 61(1)

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, medicine.drug_class, Dasatinib, Antineoplastic Agents, Tyrosine-kinase inhibitor, 03 medical and health sciences, 0302 clinical medicine, Second line, hemic and lymphatic diseases, Internal medicine, Chart review, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, medicine, Humans, Protein Kinase Inhibitors, Retrospective Studies, business.industry, Myeloid leukemia, Hematology, respiratory tract diseases, Pyrimidines, Treatment Outcome, Nilotinib, 030220 oncology & carcinogenesis, Molecular Response, business, 030215 immunology, Multi country, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0146debf06042ee560f1bcd1537ac08c
https://pubmed.ncbi.nlm.nih.gov/31409168

المؤلفون: Suddhasatta Acharyya, Paul G. Richardson, Hermann Einsele, Andreas Günther, Estella Mendelson, Sagar Lonial, Ashok Panneerselvam, Anuja Roy

المصدر: Expert review of hematology. 10(10)

مصطلحات موضوعية: Oncology, medicine.medical_specialty, Indoles, medicine.drug_class, Antineoplastic Agents, Health outcomes, Placebo, Hydroxamic Acids, Dexamethasone, Drug Administration Schedule, Bortezomib, 03 medical and health sciences, chemistry.chemical_compound, 0302 clinical medicine, Quality of life, Recurrence, Internal medicine, Panobinostat, Patient experience, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Multicenter Studies as Topic, 030212 general & internal medicine, Multiple myeloma, Neoplasm Staging, Randomized Controlled Trials as Topic, business.industry, Histone deacetylase inhibitor, Hematology, medicine.disease, Surgery, Histone Deacetylase Inhibitors, Treatment Outcome, chemistry, Drug Resistance, Neoplasm, 030220 oncology & carcinogenesis, Quality of Life, Metric (unit), business, Multiple Myeloma

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::baf0003678bc3f7257d9636bf09215bc
https://pubmed.ncbi.nlm.nih.gov/28885063

المؤلفون: Tiziano Barbui, Xiaolei Zhou, Ruben A. Mesa, Deborah S. Hunter, Jean-Jacques Kiladjian, Richard S. Levy, Giovanni Barosi, Alessandro M. Vannucchi, Margaret Squier, Catherine Copley-Merriman, Francesco Passamonti, Laurent Knoops, Claire N. Harrison, Francisco Cervantes, Haifa Kathrin Al-Ali, Estella Mendelson, Heinz Gisslinger, Andres Sirulnik

المصدر: British Journal of Haematology. 162:229-239

مصطلحات موضوعية: Male, Ruxolitinib, Pediatrics, medicine.medical_specialty, Health-related quality of life, Myelofibrosis, JAK1/JAK2 inhibitor, Quality of life, Weight loss, Surveys and Questionnaires, Nitriles, medicine, Humans, In patient, Protein Kinase Inhibitors, Aged, business.industry, Cancer, Janus Kinase 1, Hematology, Janus Kinase 2, medicine.disease, humanities, Lymphoma, Pyrimidines, Treatment Outcome, Primary Myelofibrosis, Quality of Life, Pyrazoles, Itching, Female, medicine.symptom, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55e870a5b6f31c1dc701bb107b68f828
https://doi.org/10.1111/bjh.12375

المؤلفون: Estella Mendelson, Francois-Xavier Mahon, Xiang Ji, Ming-Hui Tai, Aby Buchbinder, Giuseppe Saglio, Sonya J. Snedecor, David Ray, Pascal Edrich

المصدر: Blood. 126:1579-1579

مصطلحات موضوعية: medicine.medical_specialty, Framingham Risk Score, Philadelphia Chromosome Positive, business.industry, Immunology, Myeloid leukemia, Imatinib, Cell Biology, Hematology, Biochemistry, Imatinib mesylate, Tolerability, Nilotinib, Internal medicine, Statistical significance, medicine, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::df38d3890517f61f7e68ed6dcb67a655
https://doi.org/10.1182/blood.v126.23.1579.1579

المؤلفون: Estella Mendelson, David Ray, Aby Buchbinder, Giuseppe Saglio, An Tran-Duy, Raechelle G. Ocampo, Francois-Xavier Mahon, Sonya J. Snedecor, Pascal Edrich

المصدر: Blood. 126:5154-5154

مصطلحات موضوعية: medicine.medical_specialty, Philadelphia Chromosome Positive, business.industry, Immunology, Imatinib, Cell Biology, Hematology, Biochemistry, Discontinuation, Clinical trial, Nilotinib, Internal medicine, Cohort, medicine, Adverse effect, Off Treatment, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::823b511a5038737b783b5b507cf3ceb4
https://doi.org/10.1182/blood.v126.23.5154.5154

المؤلفون: James A. Kaye, Haitao Gao, Raafat Seifeldin, Keith L. Davis, Julian Perez Ronco, Estella Mendelson, Isabelle Cote

المصدر: Blood. 124:1857-1857

مصطلحات موضوعية: Ruxolitinib, medicine.medical_specialty, education.field_of_study, Constitutional symptoms, business.industry, Medical record, Immunology, Population, Cell Biology, Hematology, Lower risk, medicine.disease, Biochemistry, International Prognostic Scoring System, Internal medicine, medicine, Medical history, education, Myelofibrosis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::1d5c9e9307d338bd5238c92861ea0d6b
https://doi.org/10.1182/blood.v124.21.1857.1857

المؤلفون: Tamas Masszi, Katy Benjamin, Carla Boquimpani, Tomasz Szczudlo, Estella Mendelson

المصدر: Blood. 124:4547-4547

مصطلحات موضوعية: medicine.medical_specialty, education.field_of_study, business.industry, Immunology, Ponatinib, Population, Context (language use), Cell Biology, Hematology, Biochemistry, Surgery, Clinical trial, chemistry.chemical_compound, Imatinib mesylate, Nilotinib, Quality of life, chemistry, Internal medicine, medicine, education, business, Disease burden, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::baade0fce507a5c1000b7172eb50002d
https://doi.org/10.1182/blood.v124.21.4547.4547

المؤلفون: Claire N. Harrison, Laurent Knoops, Francisco Cervantes, Viktoriya Stalbovskaya, Estella Mendelson, Tiziano Barbui, Giovanni Barosi, Alessandro M. Vannucchi, Francesco Passamonti, Mahtab Marker, Heinz Gisslinger, Matthew Squires, Jean-Jacques Kiladjian, Haifa Kathrin Al-Ali

المصدر: Blood. 122:4070-4070

مصطلحات موضوعية: medicine.medical_specialty, Ruxolitinib, business.industry, Jak2 mutation, Immunology, Symptom burden, Phases of clinical research, Cell Biology, Hematology, Exploratory analysis, medicine.disease, Biochemistry, Quality of life, Family medicine, medicine, In patient, Myelofibrosis, business, health care economics and organizations, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::d30c5272c8e41b625b32fd973310ea87
https://doi.org/10.1182/blood.v122.21.4070.4070

المؤلفون: Khalid El Ouagari, Estella Mendelson, Christopher Knight

المصدر: Blood. 120:4255-4255

مصطلحات موضوعية: Ruxolitinib, Pediatrics, medicine.medical_specialty, business.industry, Cost effectiveness, Immunology, Cell Biology, Hematology, Biochemistry, Indirect costs, Quality of life, Cohort, Clinical endpoint, Medicine, business, Adverse effect, Reimbursement, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::916fac33dbdca059b50cde69e7f5a3de
https://doi.org/10.1182/blood.v120.21.4255.4255

المؤلفون: Francesco Passamonti, L. Andres Sirulnik, Richard S. Levy, Heinz Gisslinger, Giovanni Barosi, Tiziano Barbui, Xiaolei Zhou, Laurent Knoops, Estella Mendelson, Jean-Jacques Kiladjian, Alessandro M. Vannucchi, Claire N. Harrison, Dietger Niederwieser, Kati Copley-Merriman, Francisco Cervantes

المصدر: Journal of Clinical Oncology. 30:6626-6626

مصطلحات موضوعية: Health related quality of life, Cancer Research, Ruxolitinib, Pediatrics, medicine.medical_specialty, business.industry, Symptom burden, medicine.disease, Oncology, medicine, In patient, Myelofibrosis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::663f79a1056fc261beaf244f6b4efa3f
https://doi.org/10.1200/jco.2012.30.15_suppl.6626

المؤلفون: Claire N. Harrison, Haifa Kathrin Al-Ali, Francisco Cervantes, Alessandro M. Vannucchi, Jean-Jacques Kiladjian, Heinz Gisslinger, Roger J. Waltzman, Estella Mendelson, Richard S. Levy, Catherine Copley-Merriman, Xiaolei Zhou, Tiziano Barbui, Francesco Passamonti, Giovanni Barosi, Laurent Knoops, Deborah S. Hunter

المصدر: Blood. 118:795-795

مصطلحات موضوعية: Health related quality of life, medicine.medical_specialty, Ruxolitinib, Intention-to-treat analysis, business.industry, Immunology, Disease progression, Cell Biology, Hematology, medicine.disease, Biochemistry, Quality of life, Weight loss, medicine, Physical therapy, Insomnia, medicine.symptom, Myelofibrosis, business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::dcf3372446b938205e142fd679de1990
https://doi.org/10.1182/blood.v118.21.795.795

المؤلفون: Richard S. Levy, Ruben A. Mesa, Francisco Cervantes, William Sun, Srdan Verstovsek, Roger J. Waltzman, Claire N. Harrison, Estella Mendelson, Victor Sandor, Nicolas Martin

المصدر: Blood. 118:1753-1753

مصطلحات موضوعية: medicine.medical_specialty, Ruxolitinib, business.industry, Surrogate endpoint, Immunology, Cell Biology, Hematology, medicine.disease, Placebo, Biochemistry, Quality of life, Internal medicine, Statistical significance, Post-hoc analysis, medicine, Physical therapy, business, Myelofibrosis, Clin oncol, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::c99e9fbcb5c352242cc053dc1eb0b09c
https://doi.org/10.1182/blood.v118.21.1753.1753